REXULTI is not approved for the treatment of folks with dementia-linked psychosis without agitation that may possibly happen with dementia as a result of Alzheimer’s condition. Ketamine also has clinically sizeable interactions with other receptors, but these are largely weaker than its NMDA receptor antagonism.31,34 Among opioid receptors, ketamine has https://earlew111tiw9.blogcudinti.com/profile